SCHEMBL4930698

SCHEMBL4930698

COC(=O)c1cc(C#N)cnc1NCCc1cccc(F)c1.O=C(O)c1cc(Br)cnc1NCCc1cccc(F)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CSNK2A2 P19784 2/20 0.41
CSNK2A1 P68400 2/20 0.41
MAOA P21397 1/20 0.41
MAOB P27338 1/20 0.41
RPS6KB1 P23443 2/20 0.40
AKT1 P31749 1/20 0.40
KDM4E B2RXH2 3/20 0.40
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
L3MBTL1 Q9Y468 2/20 0.40
MAPT P10636 1/20 0.40
ALDH1A1 P00352 2/20 0.37
HPGD P15428 2/20 0.37
MAPK1 P28482 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
HSD17B10 Q99714 1/20 0.37
CRHBP P24387 1/20 0.36
CRHR2 Q13324 1/20 0.36
AURKA O14965 2/20 0.36
PDPK1 O15530 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1886870 0.91 RPS6KB1 (0.46) CSNK2A2CSNK2A1MAOAMAOBRPS6KB1
SCHEMBL1880290 0.85 KDM4E (0.51) CSNK2A2CSNK2A1RPS6KB1AKT1KDM4E
SCHEMBL4966742 0.74 TAAR1 (0.46) CSNK2A2CSNK2A1RPS6KB1AKT1KDM4E
SCHEMBL12638980 0.72 KDM4E (0.53) RPS6KB1AKT1KDM4EMEN1KMT2A
SCHEMBL25175693 0.72 KDR (0.49) KDM4EMEN1KMT2AMAPTALDH1A1
SCHEMBL12638986 0.70 MEN1 (0.45) CSNK2A2CSNK2A1RPS6KB1AKT1KDM4E
SCHEMBL12942164 0.69 MEN1 (0.47) KDM4EMEN1KMT2AL3MBTL1MAPT
SCHEMBL12639001 0.69 KDM4E (0.56) KDM4EMEN1KMT2AL3MBTL1MAPT
SCHEMBL870804 0.69 KDM4E (0.55) CSNK2A2CSNK2A1KDM4EMEN1KMT2A
SCHEMBL1633004 0.69 ALDH1A1 (0.45) CSNK2A2CSNK2A1MAOAMAOBRPS6KB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080132545-A1 Certain chemical entities, compositions, and methods CYTOKINETICS, INC. 2008-06-05 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080132545-A1 Certain chemical entities, compositions, and methods MYLK, MYH2, MYH10 CSNK2A2 595/4885CSNK2A1 835/4885MAOA 406/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.